Viewing nowEzemib Tablet (Ezetimibe)
Ezetimibe 10mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

MFDS item code 201707298 · Approved 2017.09.28 · Insurance code 656004770
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
This medication is used for patients with primary hypercholesterolemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia, and homozygous sitosterolemia. It helps lower lipid levels such as total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B in conjunction with dietary therapy. Particularly, its effectiveness can be enhanced when used in combination with HMG-CoA reductase inhibitors or fenofibrate. In patients with homozygous familial hypercholesterolemia, it is used together with statins when other lipid-lowering treatments are ineffective. Additionally, it serves as an adjunct to reduce elevated sitosterol and campesterol levels in patients with homozygous sitosterolemia. Overall, this medication is used to improve various lipid abnormalities associated with hypercholesterolemia.
A standard cholesterol-lowering diet should be continued during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, taken with or without food. When administered in combination with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate combination therapy with this medicine at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine concomitantly while maintaining the HMG-CoA reductase inhibitor dose. When this medicine is administered in combination with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Administration in patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Administration in older adults No dosage adjustment is necessary when administering this medicine to older adults. Concomitant administration with bile acid sequestrants This medicine should be administered 2 hours before or 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).
This medication should not be used in patients who are allergic to its components. Caution should be taken when used in conjunction with specific lipid-lowering agents (such as statins) in patients with severely impaired liver function or abnormal liver enzyme levels. Women who are pregnant or breastfeeding should not use this medication in combination with specific lipid-lowering agents. Caution is also needed when using this medication in patients with moderate to severe liver dysfunction, as the effects may differ from expectations. While this medication is generally safe, side effects such as fatigue, headache, abdominal pain, and diarrhea may occur, so consult a doctor if any unusual symptoms appear. If symptoms like muscle pain or weakness occur, notify a healthcare professional immediately, as medication may need to be discontinued in severe cases. Patients with severely impaired kidney function can use this medication, but caution is necessary depending on their condition. Since interactions may occur with other medications, it is crucial to inform your doctor of any concurrent medications. Use during pregnancy is not recommended, and consultation with a doctor is advised if planning to get pregnant or if already pregnant. During breastfeeding, caution should be exercised as this medication may be excreted in breast milk. It should not be used in children under 6 years of age, and children over 6 years should be administered under a doctor's guidance. Elderly patients can generally use this medication, but they should be monitored for different bodily reactions. This medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is advisable to maintain storage temperatures between 1°C and 30°C. Proper storage can help preserve the medication's efficacy and safety.
White to almost white oblong tablet
30 tablets (10 tablets/PTP *3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEzetimibe 10mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Shin Il Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

Ezetimibe 10mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.